AI assistant
Sending…
GALECTIN THERAPEUTICS INC — Director's Dealing 2011
Jun 29, 2011
33422_dirs_2011-06-29_a0083db6-982d-4e0a-bc9f-1e1555e23e8d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GALECTIN THERAPEUTICS INC (GALT.OB)
CIK: 0001133416
Period of Report: 2011-06-28
Reporting Person: ROME JERALD K (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-06-28 | Stock Option (Right to Buy) | $1.18 | A | 50848 | Acquired | 2021-06-28 | Common Stock (50848) | Direct |
Footnotes
F1: The option vests as to one-eighth of the shares on June 28, 2011 and thereafter quarterly in seven equal installments beginning August 12, 2011.
More from GALECTIN THERAPEUTICS INC
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Mar 31
Earnings Release
2026
Mar 31
Annual Report
2026
Mar 31
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Board/Management Information
2026
Mar 17
Director's Dealing
2026
Feb 9
Board/Management Information
2026
Jan 21